Literature DB >> 32133645

Colorectal cancer statistics, 2020.

Rebecca L Siegel1, Kimberly D Miller1, Ann Goding Sauer1, Stacey A Fedewa1, Lynn F Butterly2,3, Joseph C Anderson3,4, Andrea Cercek5, Robert A Smith6, Ahmedin Jemal1.   

Abstract

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
© 2020 American Cancer Society.

Entities:  

Keywords:  colon and rectum neoplasms; epidemiology; health disparities; screening and early detection

Year:  2020        PMID: 32133645     DOI: 10.3322/caac.21601

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  1019 in total

1.  Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.

Authors:  Yan Zhang; Yuan Wu; Zi-Ying Gong; Hai-Dan Ye; Xiao-Kai Zhao; Jie-Yi Li; Xiao-Mei Zhang; Sheng Li; Wei Zhu; Mei Wang; Ge-Yu Liang; Yun Liu; Xin Guan; Dao-Yun Zhang; Bo Shen
Journal:  Curr Med Sci       Date:  2021-04-20

Review 2.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

3.  Integration of gene expression data identifies key genes and pathways in colorectal cancer.

Authors:  Hossein Hozhabri; Ali Lashkari; Seyed-Morteza Razavi; Ali Mohammadian
Journal:  Med Oncol       Date:  2021-01-07       Impact factor: 3.064

4.  Good for Us All.

Authors:  Rachel B Issaka
Journal:  JAMA       Date:  2020-08-11       Impact factor: 56.272

5.  Is 45 the new 50 in colorectal cancer screening?

Authors:  Paul Fritsch; Clarence Wong; Michael R Kolber
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

Review 6.  Interventional Treatment of Hepatic Metastases from Colorectal Cancer.

Authors:  Patrick D Sutphin; Suvranu Ganguli
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

7.  Disparities in Cancer Prevention in the COVID-19 Era.

Authors:  John M Carethers; Rajarshi Sengupta; Rea Blakey; Antoni Ribas; Gypsyamber D'Souza
Journal:  Cancer Prev Res (Phila)       Date:  2020-09-17

8.  Influence of aspirin on prevention of colorectal cancer: an updated systematic review and meta-analysis of randomized controlled trials.

Authors:  Abdullah A Ghaddaf; Muhammad Aziz; Mohammed S Alomari; Ahmed S Abdulhamid; Fahad A Alharbi; Abdullah N Mullah; Syed Fasial Zaidi
Journal:  Int J Colorectal Dis       Date:  2021-03-08       Impact factor: 2.571

9.  Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review.

Authors:  K C Wilson; M P Flood; D Oh; N Calvin; M Michael; R G Ramsay; A G Heriot
Journal:  Ann Surg Oncol       Date:  2021-05-28       Impact factor: 5.344

10.  Involvement of IGF/IGFBP/Erk axis in the exercise-mediated preventive effects on colorectal cancer in rats.

Authors:  Saber Ghazizadeh Darband; Shirin Sadighparvar; Firouz Ghaderi Pakdel; Somayeh Naderi; Maryam Majidinia
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.